Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...

A groundbreaking study may change how doctors treat glioblastoma, one of the deadliest brain cancers. Researchers Virginia Commonwealth University have developed a powerful new therapy using an ...

The rare Antrodia cinnamomea fungus (also known as Taiwanofungus camphoratus) is only found in Taiwan, and is associated with one particular type of endangered tree. Long used for herbal medicines, ...

A research team from the University of Osaka, in collaboration with the Massachusetts Institute of Technology, has uncovered a new molecular mechanism underlying chromosome alignment during cell ...

Lipid nanoparticles without drugs can make some cancer cells swell and burst, offering a new way to target tumors resistant to existing treatments. (Nanowerk Spotlight) The ability to selectively ...

It's the most tried and true health advice: regular exercise is key to warding off obesity, aging and chronic diseases. Mountains of research also shows working out just a few days a week could slash ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...

Vitamin D is not only an essential nutrient but is also the precursor of the hormone calcitriol, which regulates the uptake of phosphate and calcium necessary for bones by the intestines, as well as ...

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...